Synlogic, Inc. (SYBX)
OTCMKTS · Delayed Price · Currency is USD
0.6375
+0.00215 (0.34%)
At close: Apr 15, 2026
Synlogic Employees
Synlogic had 1 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,005,000
Market Cap
7.46M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1 | 0 | - |
| Dec 31, 2024 | 1 | -5 | -83.33% |
| Dec 31, 2023 | 6 | -66 | -91.67% |
| Dec 31, 2022 | 72 | -12 | -14.29% |
| Dec 31, 2021 | 84 | 12 | 16.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| NKGen Biotech | 26 |
| Brainstorm Cell Therapeutics | 23 |
| Mosaic ImmunoEngineering | 8 |
| ZIVO Bioscience | 7 |
| Bioxytran | 3 |
| AccuStem Sciences | 2 |
Synlogic News
- 1 year ago - Synlogic Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 1 year ago - Synlogic Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 2 years ago - Synlogic Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 years ago - Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 2 years ago - Synlogic Adopts Limited Duration Stockholders Rights Plan - GlobeNewsWire
- 2 years ago - Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update - GlobeNewsWire
- 2 years ago - Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria - GlobeNewsWire
- 2 years ago - Synlogic Provides Corporate Update and Outlook for 2024 - GlobeNewsWire